Djamel Mokart is an expert in Critical care at Institut Paoli-Calmettes (France). As of October 2026, ScienceLeadR ranks Djamel Mokart in the top 1% of experts worldwide for Intensive Care Units and Critical Care. Djamel Mokart has authored 251 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 2 of them ongoing. SLR score: 960 (community average: 125). How the SLR is computed.

LeadR Profile

Djamel Mokart Institut Paoli-Calmettes France
960 ScienceLeadR Reputation 960
Network Map

Critical care

Subspecialties: Infectiology - Public Health - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2002 - 2026

Source: PubMed

Institut Paoli-Calmettes

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 251

Citations

Citations: 7 661 1st author: 32 Last author: 41 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Withholding Pre-emptive Antibiotics After Pancreaticoduodenectomy in Patients with Biliary Colonization: A Multicenter Propensity Score-Matched Cohort Study.
PMID 42906748 — anesthesia, bile, confidence intervals, abdominal abscess, antibiotic prophylaxis, pancreaticoduodenectomy, cohort studies, propensity score, antimicrobial stewardship, odds ratio, infections
Anaesth Crit Care Pain Med20260
ASO Visual Abstract: Post-Pancreatectomy Liver Injury after Mayo Clinic Class Ia Celiac Axis Resection: Illustration of This Newly Described Entity with Delayed Hepatic Artery Revascularization.
PMID 42758447 — hepatic artery, arteries, liver, pancreatectomy
Ann Surg Oncol20260
Unclassifiable Invasive Pulmonary Aspergillosis in the Intensive Care Unit: Insights From a Multicenter, Retrospective Cohort Study in France (2022-2024).
PMID 42682890 — mortality, cohort studies, pulmonary aspergillosis, invasive pulmonary aspergillosis, mycoses, cluster analysis, therapeutics, intensive care units, frailty, aspergillosis
Open Forum Infect Dis20260
Post-pancreatectomy Liver Injury After Mayo Clinic Class Ia Celiac Axis Resection: Illustration of This Newly Described Entity with Delayed Hepatic Artery Revascularization.
PMID 42668340 — leucovorin, alanine transaminase, pancreatic neoplasms, alanine, celiac artery, adrenal glands, mesenteric veins, neoplasms, mesenteric artery, superior, renal veins, portal vein, hepatic artery, biopsy, arteries, transaminases, liver, vena cava, inferior, pancreas, mesenteric arteries, necrosis, transplants, gastric artery, veins, pancreatectomy, renal artery
Ann Surg Oncol20260
Early red blood cell transfusion strategy in septic shock among patients with cancer: the TRANSPORT randomized controlled trial.
PMID 42616082 — cells, hemoglobins, mortality, erythrocytes, blood, erythrocyte transfusion, shock, septic, neoplasms, critical care, blood cells, intensive care units
Intensive Care Med20260

Clinical Studies 14

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 7
Phase 3 6
Phase 2 1

By status:

Completed 10
Unknown 2
Not yet recruiting 1
Recruiting 1

By type:

Interventional 13
Observational 1

By Monocentric/Multicentric:

monocentric 10
multicentric2to4 0
multicentric5to9 1
multicentricup10 3

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Early Corticosteroids in Severe Influenza Pneumonia
NCT07786662 — injections, hygiene, dexamethasone, adrenal cortex hormones, pneumonia, influenza, human, therapeutics, intensive care units, respiratory distress syndrome, random allocation, communicable diseases, injections, intravenous
Phase 3Not yet recruiting2026
JAKAHDI JAK inhibitors in acquired hemophagocytic syndrome in the ICU
2023-504513-77-00 — intensive care units, janus kinase inhibitors
Phase 2Recruiting2024

LeadR Networks

Main global connection map